Advanced Therapies Network, Phacilitate 2025

Advanced Therapies Phacilitate Conference at the Kay Bailey Hutchison Convention Center in Dallas, Texas.

Join Pharmaron from January 20th to January 23rd at the Advanced Therapies Phacilitate 2025

Join Pharmaron at the Advanced Therapies Phacilitate Conference from January 20-23, 2025, at booth #675 at the Kay Bailey Hutchison Convention Center in Dallas, TX.

Explore our comprehensive CGT and bioanalytical capabilities tailored to support your advanced therapy program. Our specialized laboratory services span the entire CGT lifecycle, from discovery to commercialization. Key capabilities include:

  • Preclinical Services: Efficacy studies, PK, tumorigenicity toxicology, bioanalysis for biodistribution and viral shedding, and immunogenicity assays (ADA/NAb, ELISpot, FluoroSpot).
  • Clinical Services: Non-GLP and GLP bioanalytical assays for biodistribution and shedding, immunogenicity assays, and comprehensive biomarker development and validation.
  • CMC/Manufacturing: Scalable suspension chromatography, plasmid, AAV process development, proprietary plasmid design, HEK cell line expertise, GMP and non-GMP cell banking, plasmid manufacturing, and IND-enabling capabilities.
  • Analytical Testing: Full-service testing solutions, including protein and viral analytics, comprehensive product characterization, potency assay development, validation, and QC release.

Pharmaron’s integrated approach ensures streamlined CGT development, fostering efficient progression toward regulatory submissions and global market entry. Meet with our team to discuss how our robust preclinical, clinical, and CMC/manufacturing services platform can accelerate your pathway to regulatory submissions and commercialization across global markets.

Our Advanced Therapies Phacilitate 2025 Schedule

Exhibit Booth # 675

Exhibit Hours
  • January 21st – 9 am to 7:30 pm
  • January 22nd – 8 am to 4 pm
  • January 23rd – 8 am to 5 pm
Talks and Posters
  • Coming Soon
Linda Randall
Associate Vice President
Biologics R&D
Susana Domingues-Vallon
Director, Scientific Marketing
Biologics & CGT
Smiling man with black vest and plaid undershirt posed in front of a plain background with a dark blue oval border.
Gerald Craig
Associate Director, Business Operations
Biologics and CGT 
Smiling man in a suit with with white collared shirt posed in front of a plain background with a dark blue oval border.
Michael Lau
Executive Director, Global Head
CGT CDMO
Chris Sadler
Director, Process Sciences
CGT CDMO

About the Advanced Therapies Phacilitate 2025

Advanced Therapies Network, Phacilitate, is the epicenter of the cell and gene therapy industry, bringing together scientists, innovators, and business leaders to explore the latest breakthroughs and commercialization strategies. This event inspires collaboration and accelerates innovation through sessions on regulatory pathways, clinical development, and manufacturing challenges, providing attendees with valuable insights to drive the future of healthcare. For registration and more, visit advancedtherapiesweek.phacilitate.com.

Request a Meeting